Silence Therapeutics plc Share Price
Stocks
SLN
US82686Q1013
Biotechnology & Medical Research
OTC Markets Traded|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.47 USD | -0.29% |
|
+13.78% | +73.85% |
| Market Cap | 369M 495M 434M 401M 696M 47.71B 707M 4.79B 1.88B 23.34B 1.86B 1.82B 80.42B | P/E 2026 * |
-17.6x | P/E 2027 * | -15.6x |
|---|---|---|---|---|---|
| Enterprise Value | 223M 299M 262M 242M 421M 28.86B 428M 2.9B 1.14B 14.12B 1.12B 1.1B 48.65B | EV / Sales 2026 * |
89.3x | EV / Sales 2027 * | 34.9x |
| Free-Float |
69.36% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Silence Therapeutics plc
| 1 day | +0.29% | ||
| 1 week | +13.78% | ||
| Current month | -3.73% | ||
| 1 month | +40.37% | ||
| 3 months | +33.29% | ||
| 6 months | +103.27% | ||
| Current year | +73.85% |
| 1 week | 8.91 |  | 11.19 |
| 1 month | 6.93 | | 11.19 |
| Current year | 4.19 | | 11.19 |
| 1 year | 4.19 | | 11.19 |
| 3 years | 1.97 | | 27.72 |
| 5 years | 1.97 | | 27.72 |
| 10 years | 1.97 | | 35 |
| Manager | Title | Age | Since |
|---|---|---|---|
Iain Ross
CEO | Chief Executive Officer | 72 | 30/11/2025 |
Rhonda Hellums
DFI | Director of Finance/CFO | 54 | 31/01/2022 |
Curtis Rambaran
CTO | Chief Tech/Sci/R&D Officer | - | 31/12/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
David Lemus
BRD | Director/Board Member | 63 | 20/06/2018 |
Iain Ross
CHM | Chairman | 72 | 31/12/2003 |
Tim McInerney
BRD | Director/Board Member | 65 | 04/05/2025 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06/07/26 | Sell | 865,112 | 0.6105% | |||
| 02/01/26 | Free | Director | 90,000 | 0.0635% | ||
| 02/01/26 | Free | Chief Technology Officer | 300,000 | 0.2117% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.29% | +13.78% | +71.31% | +97.94% | 496M | |
| -0.49% | -4.01% | +0.61% | +2.28% | 49.18B | |
| -2.93% | -0.13% | +378.16% | +584.97% | 39.58B | |
| -0.52% | +2.77% | +7.01% | +61.95% | 34.69B | |
| -0.90% | -0.97% | +29.30% | -9.20% | 34.42B | |
| -1.82% | -1.48% | +0.52% | +32.02% | 27.11B | |
| -3.37% | -4.12% | - | - | 16.21B | |
| -1.87% | +0.74% | +72.92% | +116.33% | 15.36B | |
| +1.17% | +3.10% | +15.87% | +16.79% | 14.05B | |
| -2.27% | +0.28% | +19.29% | -32.68% | 13.02B | |
| Average | -0.72% | +1.08% | +66.11% | +96.71% | 24.41B | |
| Weighted average by Cap. | -0.74% | -0.56% | +78.50% | +121.14% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.5M 3.35M 2.94M 2.71M 4.71M 323M 4.79M 32.45M 12.72M 158M 12.58M 12.31M 545M | 3.44M 4.62M 4.05M 3.74M 6.5M 446M 6.6M 44.76M 17.55M 218M 17.35M 16.97M 751M |
| Net income | -50.24M -67.42M -59.09M -54.62M -94.79M -6.5B -96.31M -653M -256M -3.18B -253M -248M -10.96B | -84.43M -113M -99.31M -91.8M -159M -10.93B -162M -1.1B -430M -5.35B -425M -416M -18.42B |
| Net Debt | -146M -195M -171M -158M -275M -18.85B -279M -1.89B -742M -9.22B -734M -718M -31.78B | -248M -333M -292M -270M -469M -32.16B -476M -3.23B -1.27B -15.73B -1.25B -1.22B -54.21B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 20/07/26 | US$10.43 | -0.67% | 294,775 |
| 17/07/26 | US$10.50 | -3.85% | 277,230 |
| 16/07/26 | US$10.92 | +4.50% | 567,829 |
| 15/07/26 | US$10.45 | +7.18% | 791,970 |
| 14/07/26 | US$9.750 | +4.95% | 338,977 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SLN Stock
Select your edition
All financial news and data tailored to specific country editions
